What is the initial treatment for croup in the emergency department (ED)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Emergency Department Treatment for Croup

The initial treatment for croup in the emergency department should include oral corticosteroids for all cases regardless of severity, with nebulized epinephrine added for moderate to severe cases. 1, 2

Initial Assessment

  • Assess for signs of respiratory distress: barking cough, stridor, hoarse voice, accessory muscle use, tracheal tug, sternal/subcostal/intercostal recession 1
  • Determine severity based on clinical presentation - mild (occasional barky cough, no stridor at rest), moderate (frequent barky cough, audible stridor at rest, some retractions), or severe (prominent stridor, marked retractions, agitation or lethargy) 2
  • Radiographic studies are generally unnecessary and should be avoided unless there is concern for an alternative diagnosis such as foreign body aspiration or bacterial tracheitis 1, 2

Treatment Algorithm

For All Croup Cases (Regardless of Severity):

  • Administer oral dexamethasone 0.6 mg/kg (maximum 10-12 mg) as first-line treatment 2, 3
  • For patients unable to tolerate oral medication (vomiting or severe respiratory distress), use intramuscular dexamethasone at the same dose 3

For Moderate to Severe Cases (Stridor at Rest or Respiratory Distress):

  • Add nebulized epinephrine 0.5 mL/kg of 1:1000 solution (maximum 5 mL) 2, 4
  • If racemic epinephrine is not available, L-epinephrine (1:1000) can be substituted at the same dosage 4
  • Recent evidence suggests that a lower dose of nebulized epinephrine (0.1 mg/kg) may be equally effective with potentially fewer side effects 5
  • Provide oxygen therapy to maintain oxygen saturation ≥94% 2

Observation and Disposition

  • Monitor the patient for at least 2 hours after the last dose of nebulized epinephrine to assess for rebound symptoms 6, 2
  • Consider hospital admission when three or more doses of racemic epinephrine are required 1, 2
  • Recent guidelines have shown that limiting hospital admission until 3 doses of racemic epinephrine are needed can reduce hospitalization rates by 37% without increasing revisits or readmissions 2

Important Considerations and Pitfalls

  • Nebulized epinephrine should not be used in children who are shortly to be discharged or on an outpatient basis due to risk of rebound symptoms 1, 2
  • The effect of nebulized epinephrine is short-lived, lasting approximately 1-2 hours, necessitating close observation 2
  • Consider bacterial tracheitis if a patient fails to respond to standard croup treatment 1
  • Ensure emergency equipment is readily available, including appropriate facemasks, airway adjuncts, and equipment for front-of-neck access if needed 1
  • Cool mist/humidified air therapy, once commonly used, has not been shown to provide additional symptom improvement and is no longer recommended as a primary treatment 7

Alternative Corticosteroid Options

  • Nebulized budesonide has been found to be effective and may be used as an alternative to oral dexamethasone, particularly when oral administration is difficult 3, 8
  • Studies have shown that nebulized budesonide, oral dexamethasone, and intramuscular dexamethasone have similar effectiveness for treating croup 8

References

Guideline

Differentiating and Managing Croup versus Bacterial Tracheitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Croup in Toddlers

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The role of corticosteroids in the treatment of croup.

Treatments in respiratory medicine, 2004

Guideline

Dexamethasone Treatment for Croup in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Current pharmacological options in the treatment of croup.

Expert opinion on pharmacotherapy, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.